JACOB SAUVE: Open Payments
NPI 1902883770 · MONTAGUE, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,340 in 53 payments from 15 companies in 2025. Trend: 2023 $925 · 2024 $1,437 · 2025 $1,340
Food & beverage: $1,340
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $273 |
| ABBVIE INC. | 7 | $205 |
| Novo Nordisk Inc | 7 | $167 |
| GlaxoSmithKline, LLC. | 2 | $130 |
| PFIZER INC. | 6 | $103 |
| Lundbeck LLC | 3 | $90 |
| Amgen Inc. | 4 | $77 |
| Exact Sciences Corporation | 3 | $61 |
| Eisai Inc. | 1 | $46 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $41 |
Products named: AIRSUPRA, QULIPTA, REXULTI, AREXVY, Ozempic, OTEZLA, Saxenda, NURTEC ODT.
Industry payments across MI — which companies pay providers there.
